Expression and activity of human Na+/l- symporter in human glioma cells by adenovirus-mediated gene delivery

Gene Therapy

Volumn 7, Issue 9, 2000, Pages 740-749

  Cho, J Y ^a   Xing, S ^a   Liu, X ^a   Buckwalter, T L F ^a   Hwa, L ^a   Sferra, T J ^a   Chiu, I M ^a   Jhiang, S M ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Gene therapy; Gliomas; Na+ l symporter; Radioiodide uptake activity; Recombinant adenovirus

Indexed keywords

CARRIER PROTEIN; RADIOACTIVE IODINE; SODIUM ION; VIRUS LARGE T ANTIGEN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE TRANSFER; GLIOMA CELL; HALF LIFE TIME; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM TRANSPORT; VIRUS RECOMBINANT; XENOGRAFT;

ADENOVIRIDAE; ANIMALIA; CUCUMBER MOSAIC VIRUS;

EID: 0034114693     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301170     Document Type: Article

References (22)

1. Kurpad SN et al. Tumor antigens in astrocytic gliomas. Glia 1995; 15: 244-256.
2. Mahaley MS et al. National survey of patterns of care for brain-tumor patients. J Neurosurg 1989; 71: 826-836.
3. Fine HA. Novel biologic therapies for malignant gliomas. Anti-angiogenesis, immunotherapy, and gene therapy. Neurol Clin 1995; 13: 827-846.
4. Shapiro WR, Shapiro JR. Biology and treatment of malignant glioma. Oncology 1998; 12: 233-240; discussion 240, 246.
5. Kaba SE, Kyritsis AP. Recognition and management of gliomas. Drugs 1997; 53: 235-244.
6. Uhm JH et al. Mechanisms of glioma invasion: role of matrix-metalloproteinases. Can J Neurol Sci 1997; 24: 3-15.
7. Mazzaferri EL. Radioiodine and other treatments and outcomes. In: Braverman LE, Utiger RD (eds). Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 7th edn. JB Lippincott Co: Philadelphia, 1996, pp 922-945.
8. Davidson BL et al. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 1993; 3: 219-223.
9. Le Gal La Salle G et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 1993; 259: 988-990.
10. Huyghe BG et al. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum Gene Ther 1995; 6: 1403-1416.
11. Smanik PA et al. Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun 1996; 226: 339-345.
12. - symporter in human thyroid tissues and salivary gland tissues. Endocrinology 1998; 139: 4416-4419.
13. Mandell RB, Mandell LZ, Link CJJ. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res 1999; 59: 661-668.
14. - symporter gene. Endocrinology 1997; 138: 4493-4496.
15. Scott AM et al. Image registration of SPECT and CT images using an external fiduciary band and three-dimensional surface fitting in metastatic thyroid cancer. J Nucl Med 1995; 36:100-103.
16. Miller CR et al. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res 1998; 58: 5738-5748.
17. Chen J et al. A glial-specific, repressible, adenovirus vector for brain tumor gene therapy. Cancer Res 1998; 58: 3504-3507.
18. Bergelson JM et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
19. Svensson U, Persson R. Entry of adenovirus2 into HeLa cells. J Virol 1984; 51: 687-694.
20. Cho J-Y et al. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice. Oncogene 1999; 18: 3659-3665.
21. He T-C ef al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514.
22. Weiss SJ et al. Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinology 1984; 114: 1090-1098.